Eugene A Trainor III's Net Worth

$135 Million

Who is Eugene A Trainor III?

Eugene A Trainor III has an estimated net worth of $135 Million. This is based on reported shares across multiple companies, which include PHARMOS CORP, PHARMION CORP, GLU MOBILE INC, INNERWORKINGS INC, INTERCELL USA, INC., AMICUS THERAPEUTICS INC, VONAGE HOLDINGS CORP, TARGACEPT INC, SUNESIS PHARMACEUTICALS INC, Transcept Pharmaceuticals Inc, Neutral Tandem Inc, SOURCEFIRE INC, ARADIGM CORP, Echo Global Logistics, Inc., INHIBITEX, INC., MYOGEN INC, ARYx Therapeutics, Inc., PEPLIN INC, HEMOSENSE INC, Data Domain, Inc., INTARCIA THERAPEUTICS, INC, and ZTI MERGER SUBSIDIARY III INC.

SEC CIK

Eugene A Trainor III's CIK is 0001172932

Past Insider Trading and Trends

2007 was Eugene A Trainor III's most active year for acquiring shares with 15 total transactions. Eugene A Trainor III's most active month to acquire stocks was the month of April. 2007 was Eugene A Trainor III's most active year for disposing of shares, totalling 28 transactions. Eugene A Trainor III's most active month to dispose stocks was the month of October. 2004 saw Eugene A Trainor III paying a total of $27,387,357.06 for 9,068,522 shares, this is the most they've acquired in one year. In 2008 Eugene A Trainor III cashed out on 10,353,357 shares for a total of $44,476,920.90, their largest year based on trade value.